AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Non-segmental Vitiligo

If approved, upadacitinib is expected to be the first systemic medication for patients with non-segmental vitiligo, addressing important treatment needs ...
The New England Journal of Medicine

Phase 3 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis

Two phase 3, randomized trials of inhaled treprostinil for idiopathic pulmonary fibrosis (IPF) were conducted on the basis of preclinical and clinical evidence of an antifibrotic mechanism. TETON-2 ...
New York Post

‘5-4-3-2-1 method’ is the money-saving hack that makes grocery shopping a cinch

Grocery shopping shouldn’t drain your energy — or your bank account. It can be draining to sit down and make a grocery list, but going to the store without a list can also lead to overspending or ...
Healio

Diabetes classifications, new medications focus of 2026 AACE type 2 diabetes algorithm

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The 2026 update of AACE’s consensus statement algorithm ...
Mashable

Moon phase today: What the Moon will look like on April 2

The biggest stories of the day delivered to your inbox.
Business Wire

Venture Global Announces Final Investment Decision and Financial Close for Phase 2 of CP2 LNG

ARLINGTON, Va.--(BUSINESS WIRE)--Today, Venture Global, Inc. (NYSE: VG) is announcing a final investment decision (FID) and successful closing of an $8.6 billion project financing for the second phase ...
FierceBiotech

AstraZeneca reveals oral GLP-1 scored phase 2 wins but holds back weight loss data

“The only thing I will say is that we have a very competitive profile,” CEO Pascal Soriot told journalists. (iStock / Getty Images Plus) AstraZeneca is taking its oral GLP-1 drug into phase 3 on the ...